Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v4-EN
Language French English
Date Updated 2017-09-21 2017-06-14
Drug Identification Number 02381710 02381710
Brand name ALOXI ALOXI
Common or Proper name Aloxi Aloxi
Company Name ELVIUM LIFE SCIENCES ELVIUM LIFE SCIENCES
Ingredients PALONOSETRON PALONOSETRON
Strength(s) 0.25MG 0.25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 0.25 mg/5 mL 0.25 mg/5 mL
ATC code A04AA A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for discontinuation Other (Please describe in comments) Other (Please describe in comments)
Anticipated discontinuation date 2017-06-13 2017-06-13
Actual discontinuation date 2017-06-13 2017-06-13
Remaining supply date 2017-06-13 2017-06-13
Discontinuation status Reversed Discontinued
Discontinuation decision reversal yes no
Tier 3 Status No No
Information on remaining supply
Company comments Purdue Pharma is discontinuing the intravenous solution. IV formulations of other 5HT3s are available in Canada. Purdue Pharma is discontinuing the intravenous solution. IV formulations of other 5HT3s are available in Canada.
Health Canada comments